Bart Sullivan will be a panelist at the American Conference Institute’s 22nd Annual Drug and Medical Litigation Conference, December 4-6 in New York City. The panel is titled “The ESI Discovery Conundrum and Scrutinizing the Effectiveness of Using Proportionality in Minimizing E-Discovery Burdens and Costs. Other panelists are Jeffrey Nass, Senior Counsel – eDiscovery with Boehringer Ingelheim USA Corp. and Lynn Reilly, Senior Director of Lighthouse E-Discovery.
Fox Galvin, LLC is a sponsor of this event which is marketed as being “the only event which brings together an exceptional in-house presence on the faculty, the top defense firms representing biopharmaceutical and medical device companies, experienced jurists from around the country, the FDA, and the DOJ. Designed for both networking and masters-level strategy sharing, this is the leading forum at which to learn winning life sciences products liability litigation strategies.” For more information about the conference, please visit: http://drugandmed.com/.